Global Tigecycline Market Size, Share, Trends and Forecast 2022-2030

Description

Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
Industry Insights

Due to the COVID-19 pandemic, the global Tigecycline market size is estimated to be worth US$ 1445.3 million in 2021 and is forecast to a readjusted size of US$ 4635.8 million by 2028 with a CAGR of 17.9% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Tigecycline market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Tigecycline landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global Tigecycline Sales Channel is wide, like Hospital Pharmacies , Retail Pharmacies. Hospital Pharmacies is the largest consumer channel.

Tigecycline can be mainly divided into Generic Drug, Original Drug.

In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.

This report focuses on Tigecycline volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Tigecycline market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, North America and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Tigecycline market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Original Drug

Generic Drug

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Pfizer (Wyeth)

Sino Biopharmaceutical

Zhejiang Hisun Pharma

Jiangsu Hansoh Pharmaceutical

Abbott

Natco Pharma

Lyka Labs Limited

Fresenius Kabi

Sandoz

APOTEX

Accord Healthcare

Amneal Pharmaceuticals

TABLE OF CONTENT

1 Tigecycline Market Overview
1.1 Product Overview and Scope of Tigecycline

1.2 Tigecycline Segment by Type

1.2.1 Global Tigecycline Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Tigecycline Segment by Application

1.3.1 Global Tigecycline Sales Comparison by Application: (2022-2028)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.4 Global Tigecycline Market Size Estimates and Forecasts

1.4.1 Global Tigecycline Revenue 2017-2028

1.4.2 Global Tigecycline Sales 2017-2028

1.4.3 Tigecycline Market Size by Region: 2017 Versus 2021 Versus 2028

2 Tigecycline Market Competition by Manufacturers

2.1 Global Tigecycline Sales Market Share by Manufacturers (2017-2022)

2.2 Global Tigecycline Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Tigecycline Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Tigecycline Manufacturing Sites, Area Served, Product Type

2.5 Tigecycline Market Competitive Situation and Trends

2.5.1 Tigecycline Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Tigecycline Players Market Share by Revenue

2.5.3 Global Tigecycline Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Tigecycline Retrospective Market Scenario by Region

3.1 Global Tigecycline Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Tigecycline Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Tigecycline Market Facts & Figures by Country

3.3.1 North America Tigecycline Sales by Country

3.3.2 North America Tigecycline Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Tigecycline Market Facts & Figures by Country

3.4.1 Europe Tigecycline Sales by Country

3.4.2 Europe Tigecycline Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Tigecycline Market Facts & Figures by Region

3.5.1 Asia Pacific Tigecycline Sales by Region

3.5.2 Asia Pacific Tigecycline Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Tigecycline Market Facts & Figures by Country

3.6.1 Latin America Tigecycline Sales by Country

3.6.2 Latin America Tigecycline Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Tigecycline Market Facts & Figures by Country

3.7.1 Middle East and Africa Tigecycline Sales by Country

3.7.2 Middle East and Africa Tigecycline Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Tigecycline Historic Market Analysis by Type

4.1 Global Tigecycline Sales Market Share by Type (2017-2022)

4.2 Global Tigecycline Revenue Market Share by Type (2017-2022)

4.3 Global Tigecycline Price by Type (2017-2022)

5 Global Tigecycline Historic Market Analysis by Application

5.1 Global Tigecycline Sales Market Share by Application (2017-2022)

5.2 Global Tigecycline Revenue Market Share by Application (2017-2022)

5.3 Global Tigecycline Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Pfizer (Wyeth)

6.1.1 Pfizer (Wyeth) Corporation Information

6.1.2 Pfizer (Wyeth) Description and Business Overview

6.1.3 Pfizer (Wyeth) Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Pfizer (Wyeth) Tigecycline Product Portfolio

6.1.5 Pfizer (Wyeth) Recent Developments/Updates

6.2 Sino Biopharmaceutical

6.2.1 Sino Biopharmaceutical Corporation Information

6.2.2 Sino Biopharmaceutical Description and Business Overview

6.2.3 Sino Biopharmaceutical Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Sino Biopharmaceutical Tigecycline Product Portfolio

6.2.5 Sino Biopharmaceutical Recent Developments/Updates

6.3 Zhejiang Hisun Pharma

6.3.1 Zhejiang Hisun Pharma Corporation Information

6.3.2 Zhejiang Hisun Pharma Description and Business Overview

6.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Zhejiang Hisun Pharma Tigecycline Product Portfolio

6.3.5 Zhejiang Hisun Pharma Recent Developments/Updates

6.4 Jiangsu Hansoh Pharmaceutical

6.4.1 Jiangsu Hansoh Pharmaceutical Corporation Information

6.4.2 Jiangsu Hansoh Pharmaceutical Description and Business Overview

6.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Product Portfolio

6.4.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates

6.5 Abbott

6.5.1 Abbott Corporation Information

6.5.2 Abbott Description and Business Overview

6.5.3 Abbott Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Abbott Tigecycline Product Portfolio

6.5.5 Abbott Recent Developments/Updates

6.6 Natco Pharma

6.6.1 Natco Pharma Corporation Information

6.6.2 Natco Pharma Description and Business Overview

6.6.3 Natco Pharma Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Natco Pharma Tigecycline Product Portfolio

6.6.5 Natco Pharma Recent Developments/Updates

6.7 Lyka Labs Limited

6.6.1 Lyka Labs Limited Corporation Information

6.6.2 Lyka Labs Limited Description and Business Overview

6.6.3 Lyka Labs Limited Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Lyka Labs Limited Tigecycline Product Portfolio

6.7.5 Lyka Labs Limited Recent Developments/Updates

6.8 Fresenius Kabi

6.8.1 Fresenius Kabi Corporation Information

6.8.2 Fresenius Kabi Description and Business Overview

6.8.3 Fresenius Kabi Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Fresenius Kabi Tigecycline Product Portfolio

6.8.5 Fresenius Kabi Recent Developments/Updates

6.9 Sandoz

6.9.1 Sandoz Corporation Information

6.9.2 Sandoz Description and Business Overview

6.9.3 Sandoz Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Sandoz Tigecycline Product Portfolio

6.9.5 Sandoz Recent Developments/Updates

6.10 APOTEX

6.10.1 APOTEX Corporation Information

6.10.2 APOTEX Description and Business Overview

6.10.3 APOTEX Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.10.4 APOTEX Tigecycline Product Portfolio

6.10.5 APOTEX Recent Developments/Updates

6.11 Accord Healthcare

6.11.1 Accord Healthcare Corporation Information

6.11.2 Accord Healthcare Tigecycline Description and Business Overview

6.11.3 Accord Healthcare Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Accord Healthcare Tigecycline Product Portfolio

6.11.5 Accord Healthcare Recent Developments/Updates

6.12 Amneal Pharmaceuticals

6.12.1 Amneal Pharmaceuticals Corporation Information

6.12.2 Amneal Pharmaceuticals Tigecycline Description and Business Overview

6.12.3 Amneal Pharmaceuticals Tigecycline Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Amneal Pharmaceuticals Tigecycline Product Portfolio

6.12.5 Amneal Pharmaceuticals Recent Developments/Updates

7 Tigecycline Manufacturing Cost Analysis

7.1 Tigecycline Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Tigecycline

7.4 Tigecycline Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Tigecycline Distributors List

8.3 Tigecycline Customers

9 Tigecycline Market Dynamics

9.1 Tigecycline Industry Trends

9.2 Tigecycline Market Drivers

9.3 Tigecycline Market Challenges

9.4 Tigecycline Market Restraints

10 Global Market Forecast

10.1 Tigecycline Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Tigecycline by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Tigecycline by Type (2023-2028)

10.2 Tigecycline Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Tigecycline by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Tigecycline by Application (2023-2028)

10.3 Tigecycline Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Tigecycline by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Tigecycline by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample